Innovation through simplicity
We are a medical device startup in the structural heart field.
Our current focus is to percutaneously treat mitral and tricuspid valve regurgitation using Transcutaneous Edge-to-Edge Repair (TEER) technique.
“Research reported in this publication was supported by the National Heart, Lung, And Blood Institute of the National Institutes of Health under Award Number R43HL147825 and National Science Foundation Award Number 2322197. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or Nation Science Foundation.”